Sitemap
Jan 31, 2022

If you can please clarify:

1) which vaccine are you specifically talking about that was tested in Brazil.

2) Efficacy was evaluated how many days after dose 2.

3) was this a randomized RCT and was the placebo group maintained as placebo?

4) how long were the participants followed for and what was the rate of breakthrough cases?

Aditi Bhargava
Aditi Bhargava

Written by Aditi Bhargava

Dr. Aditi Bhargava is a molecular neuroendocrinologist with research focus on sex differences in stress biology and immunology.

No responses yet